Sucrose prevents protein fibrillation through compaction of the tertiary structure but hardly affects the secondary structure

Amyloid fibers, implicated in a wide range of diseases, are formed when proteins misfold and stick together in long rope‐like structures. As a natural mechanism, osmolytes can be used to modulate protein aggregation pathways with no interference with other cellular functions. The osmolyte sucrose delays fibrillation of the ribosomal protein S6 leading to softer and less shaped‐defined fibrils. The molecular mechanism used by sucrose to delay S6 fibrillation was studied based on the two‐state unfolding kinetics of the secondary and tertiary structures. It was concluded that the delay in S6 fibrillation results from stabilization and compaction of the slightly expanded tertiary native structure formed under fibrillation conditions. Interestingly, this compaction extends to almost all S6 tertiary structure but hardly affects its secondary structure. The part of the S6 tertiary structure that suffered more compaction by sucrose is known to be the first part to unfold, indicating that the native S6 has entered the unfolding pathway under fibrillation conditions. Proteins 2015; 83:2039–2051. © 2015 Wiley Periodicals, Inc.

[1]  Carl Frieden,et al.  Quantitative analysis of the time course of Aβ oligomerization and subsequent growth steps using tetramethylrhodamine-labeled Aβ , 2013, Proceedings of the National Academy of Sciences.

[2]  S. Kanba,et al.  Mechanism for retardation of amyloid fibril formation by sugars in Vλ6 protein , 2013, Protein science : a publication of the Protein Society.

[3]  D. Otzen,et al.  Stabilization of the ribosomal protein S6 by trehalose is counterbalanced by the formation of a putative off-pathway species. , 2005, Journal of molecular biology.

[4]  L. Gierasch,et al.  Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant , 2006, Proceedings of the National Academy of Sciences.

[5]  M. Sierks,et al.  Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42 , 2005, Neurobiology of Disease.

[6]  P. Klemm,et al.  Three fim genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae , 1987, Molecular and General Genetics MGG.

[7]  D. Otzen,et al.  Salt-induced detour through compact regions of the protein folding landscape. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. T. Gerig,et al.  TMAO promotes fibrillization and microtubule assembly activity in the C-terminal repeat region of tau. , 2006, Biochemistry.

[9]  P. Taboada,et al.  Existence of different structural intermediates on the fibrillation pathway of human serum albumin. , 2009, Biophysical journal.

[10]  Jesper Søndergaard Pedersen,et al.  Modulation of S6 fibrillation by unfolding rates and gatekeeper residues. , 2004, Journal of molecular biology.

[11]  Syamal Roy,et al.  A small molecule chemical chaperone optimizes its unfolded state contraction and denaturant like properties , 2013, Scientific Reports.

[12]  D. Rubinsztein,et al.  Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. , 2006, Human molecular genetics.

[13]  T. Matsuo Trehalose protects corneal epithelial cells from death by drying , 2001, The British journal of ophthalmology.

[14]  J. Kelly,et al.  Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease. , 2003, Journal of molecular biology.

[15]  V. Uversky,et al.  Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.

[16]  V. Uversky,et al.  Trimethylamine‐N‐oxide‐induced folding of α‐synuclein , 2001 .

[17]  I. Roy,et al.  Effect of trehalose on protein structure , 2008, Protein science : a publication of the Protein Society.

[18]  V. Hilser,et al.  The enthalpy change in protein folding and binding: Refinement of parameters for structure‐based calculations , 1996, Proteins.

[19]  P. Fraser,et al.  Manipulating the Amyloid-β Aggregation Pathway with Chemical Chaperones* , 1999, The Journal of Biological Chemistry.

[20]  J. McLaurin,et al.  Contribution of simple saccharides to the stabilization of amyloid structure. , 2005, Biochemical and biophysical research communications.

[21]  S. N. Timasheff Solvent stabilization of protein structure. , 1995, Methods in molecular biology.

[22]  T. Ikegami,et al.  Heat of supersaturation-limited amyloid burst directly monitored by isothermal titration calorimetry , 2014, Proceedings of the National Academy of Sciences.

[23]  S. Doglia,et al.  The osmolyte betaine promotes protein misfolding and disruption of protein aggregates , 2009, Proteins.

[24]  Daniel E. Otzen,et al.  The Effect of Osmolytes on Protein Fibrillation , 2012, International journal of molecular sciences.

[25]  A J Wand,et al.  Local dynamics and stability of apocytochrome b562 examined by hydrogen exchange. , 1998, Biochemistry.

[26]  D. Turk,et al.  Amyloid fibril formation by human stefins: Structure, mechanism & putative functions. , 2010, Biochimie.

[27]  D. Otzen,et al.  We find them here, we find them there: Functional bacterial amyloid , 2008, Cellular and Molecular Life Sciences.

[28]  D. Otzen,et al.  Conformational plasticity in folding of the split beta-alpha-beta protein S6: evidence for burst-phase disruption of the native state. , 2002, Journal of molecular biology.

[29]  E. Wahle,et al.  Hofmeister salts and potential therapeutic compounds accelerate in vitro fibril formation of the N-terminal domain of PABPN1 containing a disease-causing alanine extension. , 2008, Biochemistry.

[30]  M. Proctor,et al.  Structural changes in the transition state of protein folding: alternative interpretations of curved chevron plots. , 1999, Biochemistry.

[31]  R. Riek,et al.  Biology of amyloid: structure, function, and regulation. , 2010, Structure.

[32]  R. Pappu,et al.  Unmasking the roles of N- and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation , 2013, Proceedings of the National Academy of Sciences.

[33]  Wei Wang,et al.  Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.

[34]  D. Otzen,et al.  Thermodynamics and mechanism of cutinase stabilization by trehalose , 2008, Biopolymers.

[35]  Yogendra Pratap Singh,et al.  Amyloid peptides and proteins in review. , 2007, Reviews of physiology, biochemistry and pharmacology.

[36]  G. Rose,et al.  Structure and energetics of the hydrogen-bonded backbone in protein folding. , 2008, Annual review of biochemistry.

[37]  T. Good,et al.  Two disaccharides and trimethylamine N-oxide affect Abeta aggregation differently, but all attenuate oligomer-induced membrane permeability. , 2009, Biochemistry.

[38]  Tobin R Sosnick,et al.  The folding of single domain proteins--have we reached a consensus? , 2011, Current opinion in structural biology.

[39]  M. Sierks,et al.  Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's β‐amyloid , 2005, FEBS letters.

[40]  K. Chattopadhyay,et al.  Role of Protein Stabilizers on the Conformation of the Unfolded State of Cytochrome c and Its Early Folding Kinetics , 2010, The Journal of Biological Chemistry.

[41]  D. Ejima,et al.  Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs. , 2006, Biochimica et biophysica acta.

[42]  C. Ross,et al.  Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.

[43]  G. McRae,et al.  Osmolyte controlled fibrillation kinetics of insulin: New insight into fibrillation using the preferential exclusion principle , 2009, Biotechnology progress.

[44]  N. Nukina,et al.  Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease , 2004, Nature Medicine.

[45]  Shaomin Li,et al.  Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.

[46]  Daniel E. Otzen,et al.  Conformational plasticity in folding of the split β-α-β protein S6: evidence for burst-phase disruption of the native state , 2002 .

[47]  S. Singh,et al.  Measuring and modeling hemoglobin aggregation below the freezing temperature. , 2013, The journal of physical chemistry. B.

[48]  Eduardo P Melo,et al.  Compacting proteins: pros and cons of osmolyte-induced folding. , 2010, Current protein & peptide science.

[49]  Julian P. Whitelegge,et al.  Initiation and elongation in fibrillation of ALS-linked superoxide dismutase , 2008, Proceedings of the National Academy of Sciences.

[50]  Miguel A R B Castanho,et al.  An overview of the biophysical applications of atomic force microscopy. , 2003, Biophysical chemistry.

[51]  I. Kanazawa,et al.  Chemical Chaperones Reduce Aggregate Formation and Cell Death Caused by the Truncated Machado–Joseph Disease Gene Product with an Expanded Polyglutamine Stretch , 2002, Neurobiology of Disease.

[52]  J. Grosclaude,et al.  In Vitro and In Vivo Neurotoxicity of Prion Protein Oligomers , 2007, PLoS pathogens.